Share ownership Divi's Laboratories Limited

DIVISLAB

INE361B01024

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:02 10/04/2026 pm IST			5-day change	1st Jan Change
6,116.50 ^INR	+2.76%		+4.44%	-4.32%

01/04	Avendus Spark Upgrades Divi's Laboratories to Reduce from Sell, Price Target is INR5,840	MT
12/02	Jefferies Adjusts Divi's Laboratories' Price Target to INR8,100 From INR8,000, Keeps at Buy	MT

Share class: Divi's Laboratories Limited

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	26,54,68,580	12,68,77,650 ( 47.79 %)	0	47.79 %

Major shareholders: Divi's Laboratories Limited

Name	Equities	%	Valuation
Satchandra Kiran Divi 20.34 %	5,40,00,000	20.34 %	3 806 M ₹
Nilima Prasad Divi 20.34 %	5,40,00,000	20.34 %	3 806 M ₹
Swarna Latha Divi 5.274 %	1,40,00,000	5.274 %	987 M ₹
SBI Funds Management Ltd. (Investment Management) 4.219 %	1,11,99,552	4.219 %	789 M ₹
Life Insurance Corporation of India (Investment Portfolio) 3.016 %	80,06,311	3.016 %	564 M ₹
Divis Biotech Pvt Ltd. 3.014 %	80,00,000	3.014 %	564 M ₹
Murali Krishna P. Divi 2.85 %	75,67,000	2.85 %	533 M ₹
GIC Pte Ltd. (Investment Management) 2.264 %	60,11,266	2.264 %	424 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt) 1.822 %	48,35,846	1.822 %	341 M ₹
Axis Asset Management Co. Ltd. 1.367 %	36,29,554	1.367 %	256 M ₹
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Individuals	49.02%
Institutional	21.2%
Other	3.01%
Unknown	26.77%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	49.02%
India	19.92%
Singapore	2.51%
Norway	1.35%
Sweden	0.15%
Hong Kong	0.09%
United Kingdom	0.06%
China	0.03%
Ireland	0.02%
Netherlands	0.02%
France	0.01%
Indonesia	0.01%
Japan	0.01%
Denmark	0.01%
Luxembourg	0.01%
New Zealand	0.01%

Based on 1000 largest holdings

Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.

Employees

10,542

Sector

Pharmaceuticals

More about the company